These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17090523)

  • 1. A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma.
    Liu F; Park PJ; Lai W; Maher E; Chakravarti A; Durso L; Jiang X; Yu Y; Brosius A; Thomas M; Chin L; Brennan C; DePinho RA; Kohane I; Carroll RS; Black PM; Johnson MD
    Cancer Res; 2006 Nov; 66(22):10815-23. PubMed ID: 17090523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand binding up-regulates EphA2 messenger RNA through the mitogen-activated protein/extracellular signal-regulated kinase pathway.
    Pratt RL; Kinch MS
    Mol Cancer Res; 2003 Dec; 1(14):1070-6. PubMed ID: 14707290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EphA2 as a novel molecular marker and target in glioblastoma multiforme.
    Wykosky J; Gibo DM; Stanton C; Debinski W
    Mol Cancer Res; 2005 Oct; 3(10):541-51. PubMed ID: 16254188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.
    de Tayrac M; Etcheverry A; Aubry M; Saïkali S; Hamlat A; Quillien V; Le Treut A; Galibert MD; Mosser J
    Genes Chromosomes Cancer; 2009 Jan; 48(1):55-68. PubMed ID: 18828157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.
    Cadieux B; Ching TT; VandenBerg SR; Costello JF
    Cancer Res; 2006 Sep; 66(17):8469-76. PubMed ID: 16951158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.
    Wang LF; Fokas E; Bieker M; Rose F; Rexin P; Zhu Y; Pagenstecher A; Engenhart-Cabillic R; An HX
    Oncol Rep; 2008 Jan; 19(1):151-6. PubMed ID: 18097589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of EphA2 in head and neck squamous cell carcinoma: mRNA expression, loss of heterozygosity and immunohistochemical studies.
    Rivera RS; Gunduz M; Nagatsuka H; Gunduz E; Cengiz B; Fukushima K; Beder LB; Pehlivan D; Yamanaka N; Shimizu K; Nagai N
    Oncol Rep; 2008 May; 19(5):1079-84. PubMed ID: 18425361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate glioblastoma development gene identification using concordance between copy number abnormalities and gene expression level changes.
    Lo KC; Rossi MR; LaDuca J; Hicks DG; Turpaz Y; Hawthorn L; Cowell JK
    Genes Chromosomes Cancer; 2007 Oct; 46(10):875-94. PubMed ID: 17620294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility.
    Larsen AB; Pedersen MW; Stockhausen MT; Grandal MV; van Deurs B; Poulsen HS
    Mol Cancer Res; 2007 Mar; 5(3):283-93. PubMed ID: 17374733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival.
    Ernst A; Hofmann S; Ahmadi R; Becker N; Korshunov A; Engel F; Hartmann C; Felsberg J; Sabel M; Peterziel H; Durchdewald M; Hess J; Barbus S; Campos B; Starzinski-Powitz A; Unterberg A; Reifenberger G; Lichter P; Herold-Mende C; Radlwimmer B
    Clin Cancer Res; 2009 Nov; 15(21):6541-50. PubMed ID: 19861460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
    Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
    Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas.
    Hagemann C; Anacker J; Gerngras S; Kühnel S; Said HM; Patel R; Kämmerer U; Vordermark D; Roosen K; Vince GH
    Oncol Rep; 2008 Aug; 20(2):301-8. PubMed ID: 18636190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated high-resolution genome-wide analysis of gene dosage and gene expression in human brain tumors.
    Juric D; Bredel C; Sikic BI; Bredel M
    Methods Mol Biol; 2007; 377():187-202. PubMed ID: 17634618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas.
    Rand V; Huang J; Stockwell T; Ferriera S; Buzko O; Levy S; Busam D; Li K; Edwards JB; Eberhart C; Murphy KM; Tsiamouri A; Beeson K; Simpson AJ; Venter JC; Riggins GJ; Strausberg RL
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14344-9. PubMed ID: 16186508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of expression and genome alteration reveals putative amplified target genes in esophageal cancer.
    Sugimoto T; Arai M; Shimada H; Hata A; Seki N
    Oncol Rep; 2007 Aug; 18(2):465-72. PubMed ID: 17611672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference targeting EphA2 inhibits proliferation, induces apoptosis, and cooperates with cytotoxic drugs in human glioma cells.
    Zhou Z; Yuan X; Li Z; Tu H; Li D; Qing J; Wang H; Zhang L
    Surg Neurol; 2008 Dec; 70(6):562-8; discussion 568-9. PubMed ID: 18614215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.
    Zohrabian VM; Forzani B; Chau Z; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2009 Jan; 29(1):119-23. PubMed ID: 19331140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification.
    Lopez-Gines C; Gil-Benso R; Benito R; Mata M; Pereda J; Sastre J; Roldan P; Gonzalez-Darder J; Cerdá-Nicolás M
    Neuropathology; 2008 Oct; 28(5):507-15. PubMed ID: 18410277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.